{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:10:09Z","timestamp":1792797009276,"version":"4.5.0"},"reference-count":170,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG CRC 1066\/B3"],"award-info":[{"award-number":["DFG CRC 1066\/B3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC TR128A8"],"award-info":[{"award-number":["CRC TR128A8"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG CRC 1292\/B8"],"award-info":[{"award-number":["DFG CRC 1292\/B8"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.autrev.2020.102706","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T22:47:17Z","timestamp":1605134837000},"page":"102706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Profiling and targeting connective tissue remodeling in autoimmunity - A novel paradigm for diagnosing and treating chronic diseases"],"prefix":"10.1016","volume":"20","author":[{"given":"Morten Asser","family":"Karsdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia Byers","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Shevell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Christine","family":"Bay-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rambabu Surabattula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102706_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/apt.12820","article-title":"Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar","volume":"40","author":"Karsdal","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2020.102706_bb0010","series-title":"Biochemistry of collagens, laminins and elastin","author":"Karsdal","year":"2019"},{"key":"10.1016\/j.autrev.2020.102706_bb0015","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.joca.2015.03.036","article-title":"Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use","volume":"23","author":"Kraus","year":"2015","journal-title":"Osteoarthritis.Cartilage."},{"key":"10.1016\/j.autrev.2020.102706_bb0020","series-title":"Toward precision medicine","year":"2011"},{"key":"10.1016\/j.autrev.2020.102706_bb0025","first-page":"548","article-title":"Disease versus illness in general practice","volume":"31","author":"Helman","year":"1981","journal-title":"J R Coll Gen Pract"},{"key":"10.1016\/j.autrev.2020.102706_bb0030","first-page":"1","article-title":"Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?","author":"Siebuhr","year":"2016","journal-title":"Scand.J.Rheumatol."},{"key":"10.1016\/j.autrev.2020.102706_bb0035","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.02.020","article-title":"Metabolic inflammation-a role for hepatic inflammatory pathways as drivers of comorbidities in nonalcoholic fatty liver disease?","author":"Gehrke","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2020.102706_bb0040","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/S0168-8278(16)01708-6","article-title":"Serological biomarkers of extracellular matrix remodeling predict transplant-free survival in primary Sclerosing cholangitis patients","volume":"64","author":"Nielsen","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2020.102706_bb0045","doi-asserted-by":"crossref","first-page":"G1009","DOI":"10.1152\/ajpgi.00283.2016","article-title":"Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy","volume":"311","author":"Karsdal","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.autrev.2020.102706_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30457-y","article-title":"An evaluation of the collagen fragments related to fibrogenesis and fibrolysis in nonalcoholic steatohepatitis","volume":"8","author":"Luo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102706_bb0055","doi-asserted-by":"crossref","DOI":"10.2337\/dc18-2578","article-title":"Use of plasma fragments of propeptides of type III, V, and VI procollagen for the detection of liver fibrosis in type 2 diabetes","volume":"42","author":"Bril","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autrev.2020.102706_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.joca.2013.10.018","article-title":"Osteoarthritis--a case for personalized health care?","volume":"22","author":"Karsdal","year":"2014","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.autrev.2020.102706_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2017.07.014","article-title":"The good and the bad collagens of fibrosis - their role in signaling and organ function","author":"Karsdal","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.autrev.2020.102706_bb0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004978","article-title":"The collagen family","volume":"3","author":"Ricard-Blum","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.autrev.2020.102706_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/adt.2012.474","article-title":"Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure","volume":"11","author":"Karsdal","year":"2013","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.autrev.2020.102706_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040452","article-title":"Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins","volume":"10","author":"Schuppan","year":"1990","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2020.102706_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00441-009-0866-y","article-title":"Basement membranes and human disease","volume":"339","author":"Van Agtmael","year":"2010","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0090","doi-asserted-by":"crossref","first-page":"G807","DOI":"10.1152\/ajpgi.00447.2014","article-title":"Novel insights into the function and dynamics of extracellular matrix in liver fibrosis","volume":"308","author":"Karsdal","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.autrev.2020.102706_bb0095","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1023\/A:1010616021659","article-title":"Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease","volume":"46","author":"Stickel","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2020.102706_bb0100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12265-012-9406-3","article-title":"The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium","volume":"5","author":"Dobaczewski","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/liv.14390","article-title":"Collagen biology and non-invasive biomarkers of liver fibrosis","volume":"40","author":"Karsdal","year":"2020","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.autrev.2020.102706_bb0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.30969","article-title":"Is the total amount as important as localization and type of collagen in liver fibrosis attributable to steatohepatitis?","volume":"71","author":"Karsdal","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2020.102706_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","author":"Schuppan","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.autrev.2020.102706_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-7-4","article-title":"The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?","volume":"7","author":"Genovese","year":"2014","journal-title":"FibrogenTissue Repair"},{"key":"10.1016\/j.autrev.2020.102706_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151736","article-title":"Extracellular matrix molecular remodeling in human liver fibrosis evolution","volume":"11","author":"Baiocchini","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102706_bb0130","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/apt.13819","article-title":"Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury","volume":"44","author":"Nielsen","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2020.102706_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51394-4","article-title":"Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients","volume":"9","author":"Nielsen","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102706_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040452","article-title":"Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins","author":"Schuppan","year":"1990","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2020.102706_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0676.1987.tb00324.x","article-title":"Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study","volume":"7","author":"Bentsen","year":"2008","journal-title":"Liver"},{"key":"10.1016\/j.autrev.2020.102706_bb0150","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/520609a","article-title":"Personalized medicine: time for one-person trials","volume":"520","author":"Schork","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102706_bb0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrd.2017.226","article-title":"Drug development in the era of precision medicine","volume":"17","author":"Dugger","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2020.102706_bb0160","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bpj.2011.11.3999","article-title":"Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease","volume":"102","author":"Chang","year":"2012","journal-title":"Biophys J"},{"key":"10.1016\/j.autrev.2020.102706_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/jth.13249","article-title":"Collagen-mediated hemostasis","author":"Manon-Jensen","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2020.102706_bb0170","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2337\/dc18-2599","article-title":"Markers of collagen formation and degradation reflect renal function and predict adverse outcomes in patients with type 1 diabetes","volume":"42","author":"Pilemann-Lyberg","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autrev.2020.102706_bb0175","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study","volume":"3","author":"Jenkins","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2020.102706_bb0180","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1007\/s00296-011-2237-8","article-title":"Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study","volume":"32","author":"Bay-Jensen","year":"2012","journal-title":"Rheumatol.Int."},{"key":"10.1016\/j.autrev.2020.102706_bb0185","first-page":"470","article-title":"Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study","volume":"43","author":"Bay-Jensen","year":"2014","journal-title":"SeminArthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102706_bb0190","doi-asserted-by":"crossref","DOI":"10.1080\/13547500902777608","article-title":"Biochemical markers and the FDA critical path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development","volume":"14","author":"Karsdal","year":"2009","journal-title":"Biomarkers"},{"key":"10.1016\/j.autrev.2020.102706_bb0195","first-page":"293","article-title":"Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2","volume":"46","author":"Sykes","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2020.102706_bb0200","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1016\/S0021-9258(18)55498-3","article-title":"Structural and functional characterization of a splicing mutation in the pro-alpha 2(I) collagen gene of an Ehlers-Danlos type VII patient","volume":"265","author":"Weil","year":"1990","journal-title":"J Biol Chem"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2020.102706_bb0205","first-page":"73","article-title":"Biochemical markers in osteoarthritis with lessons learned from osteoporosis","volume":"37","author":"Karsdal","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102706_bb0210","doi-asserted-by":"crossref","DOI":"10.3109\/1354750X.2011.620628","article-title":"A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M)","volume":"16","author":"Leeming","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/j.autrev.2020.102706_bb0215","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(89)92507-5","article-title":"Predisposition to familial osteoarthrosis linked to type II collagen gene","volume":"1","author":"Palotie","year":"1989","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.autrev.2020.102706_bb0220","first-page":"39","article-title":"A second mutation in the type II procollagen gene (COL2AI) causing stickler syndrome (arthro-ophthalmopathy) is also a premature termination codon","volume":"52","author":"Ahmad","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2020.102706_bb0225","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1073\/pnas.87.17.6565","article-title":"Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia","volume":"87","author":"Ala-Kokko","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102706_bb0230","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhep.2015.08.014","article-title":"Collagen and tissue turnover as a function of age: implications for fibrosis","volume":"64","author":"Karsdal","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2020.102706_bb0235","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1007\/s00296-011-2237-8","article-title":"Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study","volume":"32","author":"Bay-Jensen","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2020.102706_bb0240","doi-asserted-by":"crossref","first-page":"18789","DOI":"10.3390\/ijms151018789","article-title":"Cartilage turnover reflected by metabolic processing of type II collagen: a novel marker of anabolic function in chondrocytes","volume":"15","author":"Gudmann","year":"2014","journal-title":"Int.J.Mol.Sci."},{"key":"10.1016\/j.autrev.2020.102706_bb0245","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cvr\/cvq356","article-title":"Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers-Danlos syndrome","volume":"90","author":"Smith","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0250","first-page":"264","article-title":"Single base mutation in the type III procollagen gene that converts the codon for glycine 883 to aspartate in a mild variant of Ehlers-Danlos syndrome IV","volume":"19313\u201319317","author":"Tromp","year":"1989","journal-title":"J.Biol.Chem."},{"key":"10.1016\/j.autrev.2020.102706_bb0255","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1172\/JCI114863","article-title":"A mutation in the gene for type III procollagen (COL3A1) in a family with aortic aneurysms","volume":"86","author":"Kontusaari","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102706_bb0260","doi-asserted-by":"crossref","DOI":"10.1111\/apt.12484","article-title":"Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension","volume":"38","author":"Leeming","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2020.102706_bb0265","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102706_bb0270","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.2349482","article-title":"Identification of mutations in the COL4A5 collagen gene in Alport syndrome","volume":"248","author":"Barker","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.autrev.2020.102706_bb0275","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/ndt\/17.8.1359","article-title":"Animal models of Alport syndrome","volume":"17","author":"Kashtan","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2020.102706_bb0280","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1681\/ASN.V122252","article-title":"Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent","volume":"12","author":"Kashtan","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102706_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2016.09.003","article-title":"Characterization of serological neo-epitope biomarkers reflecting collagen remodeling in clinically stable chronic obstructive pulmonary disease","volume":"49","author":"Sand","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.autrev.2020.102706_bb0290","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tranon.2018.02.005","article-title":"Tumstatin, a Matrikine derived from collagen type IV\u03b13, is elevated in serum from patients with non\u2013small cell lung cancer","volume":"11","author":"Nielsen","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1016\/j.autrev.2020.102706_bb0295","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/jmg.35.10.846","article-title":"A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II","volume":"35","author":"Richards","year":"1998","journal-title":"J Med Genet"},{"key":"10.1016\/j.autrev.2020.102706_bb0300","first-page":"66","article-title":"COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS","volume":"1766\u20131776","author":"Wenstrup","year":"2000","journal-title":"Am.J.Hum.Genet."},{"key":"10.1016\/j.autrev.2020.102706_bb0305","doi-asserted-by":"crossref","DOI":"10.3109\/00365521.2014.996590","article-title":"Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis","volume":"50","author":"Leeming","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2020.102706_bb0310","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.clinbiochem.2012.02.007","article-title":"MMP mediated type V collagen degradation (C5M) is elevated in ankylosing spondylitis","volume":"45","author":"Veidal","year":"2012","journal-title":"Clin.Biochem."},{"key":"10.1016\/j.autrev.2020.102706_bb0315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-94-007-7893-1_12","article-title":"Collagen type VI myopathies","volume":"802","author":"Bushby","year":"2014","journal-title":"Adv.Exp.Med.Biol."},{"issue":"1\u201314","key":"10.1016\/j.autrev.2020.102706_bb0320","article-title":"Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease","volume":"12","author":"Fenton","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102706_bb0325","doi-asserted-by":"crossref","DOI":"10.1007\/s13539-013-0114-x","article-title":"Type VI collagen turnover-related peptides-novel serological biomarkers of muscle mass and anabolic response to loading in young men","volume":"4","author":"Nedergaard","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.autrev.2020.102706_bb0330","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1600-0625.2008.00723.x","article-title":"Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa","volume":"17","author":"Dang","year":"2008","journal-title":"Exp Dermatol"},{"issue":"Pt 2","key":"10.1016\/j.autrev.2020.102706_bb0335","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1242\/jcs.112.21.3641","article-title":"Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa","volume":"112","author":"Heinonen","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1016\/j.autrev.2020.102706_bb0340","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/adt.2017.820","article-title":"Development of a neo-epitope specific assay for serological assessment of type VII collagen turnover and its relevance in fibroproliferative disorders","volume":"16","author":"Sand","year":"2018","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.autrev.2020.102706_bb0345","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/15384047.2018.1550571","article-title":"Vastatin (the NC1 domain of human type VIII collagen a1 chain) is linked to stromal reactivity and elevated in serum from patients with colorectal cancer","volume":"20","author":"Willumsen","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.autrev.2020.102706_bb0350","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1086\/324023","article-title":"A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity","volume":"69","author":"Czarny-Ratajczak","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2020.102706_bb0355","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/humu.21611","article-title":"Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution","volume":"33","author":"Jackson","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.autrev.2020.102706_bb0360","series-title":"Multiple epiphyseal dysplasia, dominant","author":"Briggs","year":"1993"},{"key":"10.1016\/j.autrev.2020.102706_bb0365","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/jor.21161","article-title":"Early-onset metaphyseal chondrodysplasia type Schmid associated with a COL10A1 frame-shift mutation and impaired trimerization of wild-type \u03b11(X) protein chains","volume":"28","author":"M\u00e4kitie","year":"2010","journal-title":"J Orthop Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00776-011-0021-y","article-title":"Schmid-type metaphyseal chondrodysplasia as the result of a collagen type X defect due to a novel COL10A1 nonsense mutation: a case report of a novel COL10A1 mutation","volume":"16","author":"Woelfle","year":"2011","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.autrev.2020.102706_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.joca.2019.01.001","article-title":"Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis","volume":"27","author":"He","year":"2019","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.autrev.2020.102706_bb0380","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1073\/pnas.98.3.1194","article-title":"Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice","volume":"98","author":"Eklund","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102706_bb0385","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1006\/bbrc.1999.0248","article-title":"Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin","volume":"255","author":"Ramchandran","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2020.102706_bb0390","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.matbio.2012.03.003","article-title":"Tumor suppression by collagen XV is independent of the restin domain","volume":"31","author":"Mutolo","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.autrev.2020.102706_bb0395","first-page":"2075","article-title":"Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney","volume":"150","author":"H\u00e4gg","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2020.102706_bb0400","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1093\/hmg\/ddt365","article-title":"Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis","volume":"22","author":"Connelly","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2020.102706_bb0405","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/jid.2013.308","article-title":"Long-term survival of type XVII collagen revertant cells in an animal model of revertant cell therapy","volume":"134","author":"Gosty\u0144ski","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102706_bb0410","first-page":"942","article-title":"Type XVIII collagen is essential for survival during acute liver injury in mice","volume":"6","author":"Duncan","year":"2013","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.autrev.2020.102706_bb0415","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/emboj\/21.7.1535","article-title":"Lack of collagen XVIII\/endostatin results in eye abnormalities","volume":"21","author":"Fukai","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2020.102706_bb0420","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.matbio.2010.11.001","article-title":"The multiple functions of collagen XVIII in development and disease","volume":"30","author":"Seppinen","year":"2011","journal-title":"Matrix Biol"},{"key":"10.1016\/j.autrev.2020.102706_bb0425","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2001-17556","article-title":"Matrix as a modulator of hepatic fibrogenesis","volume":"21","author":"Schuppan","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2020.102706_bb0430","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102706_bb0435","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mt.2016.56","article-title":"Vastatin is an endogenous antiangiogenesis polypeptide lost in hepatocellular carcinoma and effectively inhibits tumor metastasis","volume":"24","author":"Shen","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.autrev.2020.102706_bb0440","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1535-6108(03)00133-8","article-title":"Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 protelysis and suppress angioenesis via alphaVbeta3 integrin","volume":"3","author":"Hamano","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.autrev.2020.102706_bb0445","doi-asserted-by":"crossref","first-page":"136ra71","DOI":"10.1126\/scitranslmed.3003421","article-title":"A peptide derived from endostatin ameliorates organ fibrosis","volume":"4","author":"Yamaguchi","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2020.102706_bb0450","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1172\/JCI63930","article-title":"Adipocyte-derived endotrophin promotes malignant tumor progression","volume":"122","author":"Park","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102706_bb0455","first-page":"1","article-title":"Serum endotrophin identifies optimal responders to PPAR\u03b3 agonists in type 2 diabetes","author":"Karsdal","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.autrev.2020.102706_bb0460","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1074\/jbc.275.2.1209","article-title":"Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth","volume":"275","author":"Kamphaus","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102706_bb0465","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1535-6108(03)00133-8","article-title":"Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin","volume":"3","author":"Hamano","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.autrev.2020.102706_bb0470","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mvr.2007.05.005","article-title":"Type IV collagen-derived angiogenesis inhibitors","volume":"74","author":"Mundel","year":"2007","journal-title":"Microvasc Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0475","first-page":"2520","article-title":"Anti-angiogenic cues from vascular basement membrane collagen","volume":"60","author":"Colorado","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0480","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbrc.2006.12.231","article-title":"Identification of novel short peptides derived from the \u03b14, \u03b15 and \u03b16 fibrils of type IV collagen with anti-angiogenic properties","volume":"354","author":"Karagiannis","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2020.102706_bb0485","doi-asserted-by":"crossref","first-page":"16607","DOI":"10.1074\/jbc.M510192200","article-title":"The C5 domain of the collagen VI \u03b13(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells","volume":"281","author":"Lamand\u00e9","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102706_bb0490","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1006\/bbrc.2001.6227","article-title":"The C5 domain of Col6A3 is cleaved off from the Col6 fibrils immediately after secretion","volume":"290","author":"Aigner","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2020.102706_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4485","article-title":"Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction","volume":"5","author":"Sun","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2020.102706_bb0500","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.18632\/oncotarget.796","article-title":"Endotrophin \u2013 linking obesity with aggressive tumor growth","volume":"33","author":"Park","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2020.102706_bb0505","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/bbrc.2001.5970","article-title":"NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis","volume":"289","author":"Xu","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2020.102706_bb0510","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0140-6736(05)60006-2","article-title":"Hepatocytes as a source of collagen type XVIII endostatin","volume":"352","author":"Schuppan","year":"1998","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.autrev.2020.102706_bb0515","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10456-016-9533-6","article-title":"An extracellular proteasome releases endostatin from human collagen XVIII","volume":"20","author":"Reiss-Pistilli","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.autrev.2020.102706_bb0520","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2005.06.011","article-title":"Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans","volume":"333","author":"Reis","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2020.102706_bb0525","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1097-2765(01)00225-8","article-title":"Cell surface glypicans are low-affinity endostatin receptors","volume":"7","author":"Karumanchi","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.autrev.2020.102706_bb0530","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2174\/092986612802084465","article-title":"Characterization of the interaction between endostatin short peptide and VEGF receptor 3","volume":"19","author":"Han","year":"2012","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.autrev.2020.102706_bb0535","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2007-01-064428","article-title":"Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin","volume":"110","author":"Shi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2020.102706_bb0540","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10456-012-9284-y","article-title":"The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells","volume":"15","author":"Song","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.autrev.2020.102706_bb0545","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-14-56","article-title":"Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats","volume":"14","author":"Wan","year":"2013","journal-title":"Respir.Res."},{"key":"10.1016\/j.autrev.2020.102706_bb0550","doi-asserted-by":"crossref","first-page":"136ra71","DOI":"10.1126\/scitranslmed.3003421","article-title":"A peptide derived from endostatin ameliorates organ fibrosis","volume":"4","author":"Yamaguchi","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2020.102706_bb0555","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13075-020-02169-0","article-title":"Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis","volume":"22","author":"Li","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102706_bb0560","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-015-0913-x","article-title":"Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study","volume":"18","author":"Bay-Jensen","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102706_bb0565","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1479-5876-10-195","article-title":"Matrix metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis","volume":"10","author":"Siebuhr","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2020.102706_bb0570","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/1756-185X.13804","article-title":"Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis","volume":"23","author":"Kubo","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102706_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207324","article-title":"Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: a cross-sectional study","volume":"13","author":"Juhl","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102706_bb0580","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42358-019-0063-y","article-title":"Anti-collagen type v: a marker of early systemic sclerosis?","volume":"59","author":"Ugolini-Lopes","year":"2019","journal-title":"Adv Rheumatol (London, England)"},{"key":"10.1016\/j.autrev.2020.102706_bb0585","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1183\/09031936.00105314","article-title":"Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis","volume":"45","author":"Wilkes","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2020.102706_bb0590","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.3389\/fimmu.2019.03012","article-title":"Fc\u03b3 receptor IIB controls skin inflammation in an active model of Epidermolysis Bullosa Acquisita","volume":"10","author":"Kovacs","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102706_bb0595","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1523-1747.2002.01772.x","article-title":"The Epidermolysis Bullosa Acquisita antigen (type VII collagen) is present in human colon and patients with Crohn\u2019s disease have autoantibodies to type VII collagen","volume":"118","author":"Chen","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102706_bb0600","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/gut.2005.069385","article-title":"Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease","volume":"55","author":"Dieterich","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2020.102706_bb0605","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.matbio.2009.03.005","article-title":"Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III","volume":"28","author":"Lebbink","year":"2009","journal-title":"Matrix Biol"},{"key":"10.1016\/j.autrev.2020.102706_bb0610","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2353\/ajpath.2009.081170","article-title":"Emerging concepts in the pathogenesis of lung fibrosis","volume":"175","author":"Hardie","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2020.102706_bb0615","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1165\/rcmb.2009-0318OC","article-title":"Human lung parenchyma but not proximal bronchi produces fibroblasts with enhanced TGF-beta signaling and alpha-SMA expression","volume":"43","author":"Pechkovsky","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.autrev.2020.102706_bb0620","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8","article-title":"Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis","volume":"43","author":"Jelaska","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102706_bb0625","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","article-title":"Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies","volume":"50","author":"Popov","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2020.102706_bb0630","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2020.102706_bb0635","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0008-6363(00)00030-4","article-title":"Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis","volume":"46","author":"MacKenna","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0640","first-page":"3","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study","volume":"462\u2013472","author":"Jenkins","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2020.102706_bb0645","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-019-1118-7","article-title":"Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort","volume":"20","author":"Organ","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0650","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12931-015-0225-3","article-title":"Accelerated extracellular matrix turnover during exacerbations of COPD","volume":"16","author":"Sand","year":"2015","journal-title":"Respir Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0655","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1038\/jid.2015.188","article-title":"Suppression of T cell activation and collagen accumulation by an anti-IFNAR1 mAb, Anifrolumab, in adult patients with systemic sclerosis","volume":"135","author":"Guo","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102706_bb0660","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1346-8138.2009.00738.x","article-title":"Mechanisms of skin fibrosis in systemic sclerosis","volume":"37","author":"Jinnin","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2020.102706_bb0665","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/liv.12700","article-title":"Plasma pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C","volume":"35","author":"Nielsen","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2020.102706_bb0670","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clinbiochem.2010.03.015","article-title":"Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers--are they the cause or the consequence of the disease?","volume":"43","author":"Karsdal","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.autrev.2020.102706_bb0675","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.3748\/wjg.14.4120","article-title":"Hepatic steatosis: a benign disease or a silent killer","volume":"14","author":"El-Zayadi","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2020.102706_bb0680","first-page":"129","article-title":"Heart disease and stroke statistics\u20142014 update","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2020.102706_bb0685","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-0038-1657566","article-title":"Platelet receptors for collagen","volume":"78","author":"Moroi","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2020.102706_bb0690","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1182\/blood.V91.10.3808","article-title":"Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via alpha2 beta1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces","volume":"91","author":"Verkleij","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2020.102706_bb0695","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","article-title":"Platelet secretion: from haemostasis to wound healing and beyond","volume":"29","author":"Golebiewska","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.autrev.2020.102706_bb0700","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/S0006-3495(03)74822-X","article-title":"Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates","volume":"85","author":"Kumar","year":"2003","journal-title":"Biophys J"},{"key":"10.1016\/j.autrev.2020.102706_bb0705","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0008-6363(98)00306-X","article-title":"Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen","volume":"41","author":"Knight","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0710","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1074\/jbc.275.1.35","article-title":"The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens","volume":"275","author":"Knight","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102706_bb0715","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1042\/bj2990791","article-title":"Conformation-dependent platelet adhesion to collagen involving integrin alpha 2 beta 1-mediated and other mechanisms: multiple alpha 2 beta 1-recognition sites in collagen type I","author":"Morton","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2020.102706_bb0720","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1111\/j.1538-7836.2006.02111.x","article-title":"von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen","volume":"4","author":"BONNEFOY","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2020.102706_bb0725","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1016\/S0021-9258(19)76501-6","article-title":"Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III","volume":"262","author":"Pareti","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102706_bb0730","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/ATVBAHA.111.241067","article-title":"Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity","volume":"32","author":"Loyau","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2020.102706_bb0735","doi-asserted-by":"crossref","first-page":"46197","DOI":"10.1074\/jbc.M204029200","article-title":"Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen","volume":"277","author":"Miura","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102706_bb0740","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gut.33.4.502","article-title":"Circulating von Willebrand factor in inflammatory bowel disease","volume":"33","author":"Stevens","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2020.102706_bb0745","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0301-2115(00)00490-5","article-title":"The endothelium: vascular control of haemostasis","volume":"95","author":"van Hinsbergh","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.autrev.2020.102706_bb0750","first-page":"1","article-title":"Extracellular matrix proteins in hemostasis and thrombosis","author":"Bergmeier","year":"2012","journal-title":"Curr Ther Vasc Endovasc Surg"},{"key":"10.1016\/j.autrev.2020.102706_bb0755","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00441-016-2440-8","article-title":"Contribution of collagen adhesion receptors to tissue fibrosis","volume":"365","author":"Coelho","year":"2016","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0760","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1538-7836.2004.00665.x","article-title":"The role of collagen in thrombosis and hemostasis","volume":"2","author":"Farndale","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2020.102706_bb0765","first-page":"8","article-title":"MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis - validation of two novel biomarker assays","author":"Sand","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102706_bb0770","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar4266","article-title":"Serological identification of fast progressors of structural damage with rheumatoid arthritis","volume":"15","author":"Siebuhr","year":"2013","journal-title":"Arthritis ResTher"},{"key":"10.1016\/j.autrev.2020.102706_bb0775","article-title":"Increased remodelling of interstitial collagens and basement membrane is suppressed by treatment in patients with rheumatoid arthritis: serological evaluation of a one-year prospective study of 149 Japanese patients","volume":"36","author":"Gudmann","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102706_bb0780","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/er.2010-0006","article-title":"Osteoclast activity and subtypes as a function of physiology and pathology--implications for future treatments of osteoporosis","volume":"32","author":"Henriksen","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.autrev.2020.102706_bb0785","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1359\/jbmr.2000.15.4.621","article-title":"True strength","volume":"15","author":"Weinstein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.autrev.2020.102706_bb0790","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/gerona\/gly163","article-title":"Bone and soft tissue turnover in relation to all-cause mortality in postmenopausal women","volume":"74","author":"Bager","year":"2019","journal-title":"J Gerontol Ser A"},{"key":"10.1016\/j.autrev.2020.102706_bb0795","doi-asserted-by":"crossref","DOI":"10.2165\/00003495-200666150-00002","article-title":"Optimising antiresorptive therapies in postmenopausal women: why do we need to give due consideration to the degree of suppression?","volume":"66","author":"Karsdal","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.autrev.2020.102706_bb0800","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/liv.12700","article-title":"Plasma pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C","volume":"35","author":"Nielsen","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2020.102706_bb0805","doi-asserted-by":"crossref","DOI":"10.3109\/1354750X.2011.557440","article-title":"Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development","volume":"16","author":"Leeming","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/j.autrev.2020.102706_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2011.08.1135","article-title":"Protein fingerprints - relying on and understanding the information of serological protein measurements","volume":"44","author":"Karsdal","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.autrev.2020.102706_bb0815","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-11-125","article-title":"Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis - the effect of sex, Kellgren-Lawrence (KL) score, Body Mass Index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation","volume":"11","author":"Karsdal","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.autrev.2020.102706_bb0820","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/annrheumdis-2016-209252","article-title":"Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA biomarkers consortium","volume":"76","author":"Kraus","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102706_bb0825","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s13238-017-0377-7","article-title":"The minor collagens in articular cartilage","volume":"8","author":"Luo","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.autrev.2020.102706_bb0830","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/art.20332","article-title":"A new marker for osteoarthritis: cross-sectional and longitudinal approach","volume":"50","author":"Reijman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102706_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2020.03.002","article-title":"Clinical and biochemical factors associated with risk of total joint replacement and radiographic progression in osteoarthritis: data from two phase III clinical trials","author":"Bihlet","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102706_bb0840","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2019.14735","article-title":"Effect of intra-articular sprifermin vs placebo on femorotibial joint cartilage thickness in patients with osteoarthritis","volume":"322","author":"Hochberg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2020.102706_bb0845","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41588-018-0327-1","article-title":"Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data","volume":"51","author":"Tachmazidou","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2020.102706_bb0850","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/13547500903434519","article-title":"Should biochemical markers of bone turnover be considered standard practice for safety pharmacology?","volume":"15","author":"Henriksen","year":"2020","journal-title":"Biomarkers"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:19:54Z","timestamp":1761599994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220302858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1568997220302858"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102706","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling and targeting connective tissue remodeling in autoimmunity - A novel paradigm for diagnosing and treating chronic diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102706"}}